Effect of Liraglutide on Macrophage Polarization in Human Adipose Tissue and Peripheral Blood

Trial Profile

Effect of Liraglutide on Macrophage Polarization in Human Adipose Tissue and Peripheral Blood

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 15 Feb 2018

At a glance

  • Drugs Liraglutide (Primary)
  • Indications Obesity; Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 11 Feb 2018 Planned End Date changed from 1 Mar 2017 to 1 Aug 2018.
    • 11 Feb 2018 Planned primary completion date changed from 1 Mar 2017 to 1 Aug 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top